Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Pediatric Hematology · Aplastic anemia–intellectual disability–dwarfism syndrome

Understanding AMeDS: A Guide for Families

At a Glance

AMeDS is an ultra-rare inherited bone marrow failure syndrome linked to ADH5 and ALDH2 changes. It can cause low blood counts, short stature, and intellectual disability, so children need individualized hematology care, urgent evaluation for fever or bleeding, and ongoing monitoring.

Receiving a diagnosis of AMeDS (Aplastic Anemia, Mental Retardation, and Dwarfism Syndrome) often comes after a long and exhausting “diagnostic odyssey” [1]. (Note: “Mental retardation” is an obsolete and stigmatizing term, and modern specialists prefer to describe it as an intellectual disability, but the original acronym AMeDS remains in use). Because this syndrome is ultra-rare, you may find that many doctors you encounter have never seen a case before. It is common to feel a mix of relief at finally having a name for your child’s condition and overwhelming concern about what the future holds.

AMeDS is an inherited bone marrow failure syndrome (IBMFS) [2]. This means it is caused by specific changes in a child’s genetic code—specifically the ADH5 and ALDH2 genes—that they were born with, rather than an outside “attack” on the body [2][3]. These genetic changes make it difficult for the body to clear a natural chemical called formaldehyde, leading to DNA damage that eventually causes the bone marrow to stop producing enough blood cells [2][4].

The Core Features of AMeDS

While every child is different and features vary widely, AMeDS is typically identified in the literature by a “triad” of three core findings:

  1. Aplastic Anemia (Bone Marrow Failure): The bone marrow (the “factory” inside bones) slows down or stops making red blood cells, white blood cells, and platelets [5].
  2. Short Stature (Dwarfism): Growth failure is a hallmark of the syndrome. Children are often much smaller than their peers [5][6].
  3. Intellectual Disability: There are typically delays in reaching developmental milestones or challenges with learning and cognitive function [5][2].

In some cases, children may also have a small head size (microcephaly), changes in skin color or patches (pigmentary changes), or structural differences in their bones [5][6].

AMeDS vs. Acquired Aplastic Anemia

It is important to distinguish AMeDS from “acquired” aplastic anemia. In the acquired version, the immune system mistakenly attacks healthy bone marrow [3]. Because the cause is different, the treatment often differs as well. For example, immunosuppressive therapy (drugs that quiet the immune system) is a standard treatment for the acquired version but is generally not effective for the genetic cause of AMeDS [7][8]. For AMeDS, the primary focus is on supportive care (like transfusions) or considering a hematopoietic stem cell transplant (bone marrow transplant) to replace the failing “factory” [8].

Medical Emergencies: When to Seek Immediate Care

The bone marrow failure aspect of AMeDS can lead to pancytopenia (low levels of all three blood cell types), which creates specific, life-threatening risks. You should have a written emergency plan from your hematology team detailing exactly when to call their 24-hour number versus when to go to the emergency room. The following are red flags that require immediate evaluation:

1. Neutropenic Fever (Infection Risk)

When white blood cells (specifically neutrophils, measured as the absolute neutrophil count or ANC) are very low, the body cannot fight off bacteria. In these children, a simple fever can rapidly turn into sepsis (a life-threatening response to infection) [9].

  • Action: Seek emergency care immediately for any temperature over the threshold set by your hematologist (often 100.4°F or 38.0°C). Follow your center’s advice on the preferred thermometer method. Never use a rectal thermometer when neutrophils or platelets are low.
  • Watch for: Shaking chills (rigors), extreme sleepiness, or confusion [9]. Do not wait for these symptoms to appear before seeking help for a fever.

2. Severe Thrombocytopenia (Bleeding Risk)

Low platelets mean the blood cannot clot properly. This can lead to dangerous internal or external bleeding [6].

  • Action: Seek emergency care for uncontrollable nosebleeds, mucosal bleeding, vomiting blood, or black/tarry stools.
  • Watch for: Petechiae—tiny, flat red or purple spots that look like a rash but do not fade when pressed. Call your care team if you notice new bruising or petechiae [6].
  • Neurologic Changes: A sudden, severe headache, head trauma, blurred vision, or weakness can signal bleeding in the brain and is a 911 emergency.

3. Severe Anemia (Oxygen Depletion)

When red blood cells are too low, the heart and lungs have to work much harder to move oxygen through the body.

  • Action: Seek emergency care if your child is struggling to breathe, has a racing heart rate while resting, or faints.

Long-Term Monitoring

Because AMeDS is a complex syndrome, care involves more than just monitoring blood counts. Based on sparse reports in the medical literature, there is a risk that the bone marrow failure could evolve into other conditions, such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) [5][8]. This progression is not an inevitability, but regular check-ups with a pediatric hematologist who specializes in “inherited” syndromes are essential to track your child’s health closely. While the physical and cognitive challenges are lifelong, early intervention and a dedicated care team can help manage symptoms and improve quality of life [5].

Common questions in this guide

What is AMeDS, and what causes it?
AMeDS is an ultra-rare inherited bone marrow failure syndrome. It results from changes in the ADH5 and ALDH2 genes, which help the body clear formaldehyde; buildup can damage DNA and impair blood cell production. The syndrome often includes aplastic anemia, short stature, and intellectual disability.
What health problems can AMeDS cause in children?
AMeDS can cause low levels of red blood cells, white blood cells, and platelets, along with short stature and intellectual or developmental difficulties. Some children also have microcephaly, pigmentary skin changes, or skeletal differences. Low blood counts can increase the risks of infection, bleeding, and problems caused by anemia.
How is AMeDS different from acquired aplastic anemia?
AMeDS results from inherited genetic changes, while acquired aplastic anemia usually occurs when the immune system attacks the bone marrow. Medicines that suppress the immune system are generally not effective for the genetic cause of AMeDS. Care may instead focus on transfusions and other supportive measures, with a stem cell transplant considered in some cases.
When is a fever in a child with AMeDS an emergency?
A temperature at or above the threshold set by the child’s hematologist, often 100.4°F or 38.0°C, requires immediate medical evaluation when neutrophil levels are low. Infection can worsen quickly and lead to sepsis, even if the child has few other symptoms. Follow the care team’s thermometer instructions and never use a rectal thermometer when neutrophils or platelets are low.
Which bleeding symptoms need urgent medical attention?
Uncontrollable nosebleeds, bleeding from the mouth, vomiting blood, or black or tarry stools require emergency evaluation. A sudden severe headache, head injury, blurred vision, or weakness may signal bleeding in the brain and requires emergency help. New bruising or petechiae should be reported promptly to the care team.
What treatment and follow-up does a child with AMeDS need?
Treatment may include supportive care, blood transfusions, and consideration of a hematopoietic stem cell transplant. Regular follow-up with a pediatric hematologist should include blood counts as well as growth and developmental monitoring. Because bone marrow failure can sometimes progress to myelodysplastic syndrome or acute myeloid leukemia, ongoing surveillance is important, although progression is not inevitable.
Do children with AMeDS need specially processed blood products?
Some children may need blood products with specific processing, such as leukoreduction or irradiation, depending on their treatment plan and transplant considerations. The hematology team should identify the appropriate product specifications before a transfusion is needed. Families should carry or keep this information with the child’s emergency plan.

Get notified when new evidence is published on Aplastic anemia-intellectual disability-dwarfism syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Genomic insights into inherited bone marrow failure syndromes in a Korean population.

    Lee JM, Kim HS, Yoo J, et al.

    British journal of haematology 2024; (205(4)):1581-1589 doi:10.1111/bjh.19509.

    PMID: 38735735
  2. 2

    Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome.

    Oka Y, Hamada M, Nakazawa Y, et al.

    Science advances 2020; (6(51)) doi:10.1126/sciadv.abd7197.

    PMID: 33355142
  3. 3

    The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults.

    Piekarska A, Pawelec K, Szmigielska-Kapłon A, Ussowicz M

    Frontiers in immunology 2024; (15()):1378432 doi:10.3389/fimmu.2024.1378432.

    PMID: 38646536
  4. 4

    Endogenous aldehyde-induced DNA-protein crosslinks are resolved by transcription-coupled repair.

    Oka Y, Nakazawa Y, Shimada M, Ogi T

    Nature cell biology 2024; (26(5)):784-796 doi:10.1038/s41556-024-01401-2.

    PMID: 38600234
  5. 5

    Characteristic phenotypes of ADH5/ALDH2 deficiency during childhood.

    Matsumoto M, Oyake M, Itonaga T, et al.

    European journal of medical genetics 2024; (69()):104939 doi:10.1016/j.ejmg.2024.104939.

    PMID: 38614309
  6. 6

    A case of ADH5/ALDH2 deficiency combined with 3q29 microduplication syndrome.

    Chenzhuo S, Lingling F, Ang W, et al.

    BMC pediatrics 2025; (25(1)):717 doi:10.1186/s12887-025-05948-3.

    PMID: 41039406
  7. 7

    Immunosuppressive therapy in severe aplastic anemia.

    Patel BA, Townsley DM, Scheinberg P

    Seminars in hematology 2022; (59(1)):21-29 doi:10.1053/j.seminhematol.2022.01.002.

    PMID: 35491055
  8. 8

    Cord Blood Transplantation Using Myeloablative Conditioning for Pediatric Advanced Myelodysplastic Syndrome in AMeD Syndrome With a Novel ADH5 Variant.

    Morishita Y, Hamada M, Uemura S, et al.

    Pediatric blood & cancer 2025; (72(2)):e31465 doi:10.1002/pbc.31465.

    PMID: 39616414
  9. 9

    Extracorporeal Membrane Oxygenation in Pediatric Severe Aplastic Anemia: A Case Report Highlighting Risk-Benefit and Ethical Considerations.

    Abraham AS, Mathew MM, Thomas L, et al.

    Cureus 2026; (18(3)):e105764 doi:10.7759/cureus.105764.

    PMID: 42037822

This page is for informational purposes only and does not constitute medical advice about your child’s AMeDS. Follow your child’s hematology team for individualized decisions about symptoms, transfusions, emergency care, and treatment.